The company has installed over 300 PCT systems in approximately 200 sites worldwide. Primary development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. The company completed a Merger/Acquisition with Uncle Buds Hemp on January 22, 2024, expanding into consumer wellness products alongside its core laboratory instrumentation business.
Cyborg Score Rationale
PBIO has solid technology foundations with 300+ installed systems and peer-reviewed scientific validation. However, as a micro-cap OTC stock with minimal revenue and persistent losses, the company faces significant commercialization challenges and limited financial resources for scaling operations.
Top Insights
Three proprietary pressure-based technology platforms create diversified revenue opportunities across sample preparation, protein therapeutics, and nanoemulsion markets
January 2024 Uncle Bud's acquisition signals forward-integration strategy into consumer wellness, diversifying from laboratory-only revenue model
Over 120 peer-reviewed publications and installations across 200 academic/pharma/biotech sites provide strong scientific validation and network effects
Micro-cap market structure (OTCQB listed) limits capital access and institutional adoption despite strong technology fundamentals
Named Competitors
Sample Preparation Systems — Diversified lab instrumentation and analytical solutions
Alternative Sample Prep Methods — Chromatography and mass spectrometry sample preparation
Protein Purification Systems — Biopharmaceutical manufacturing and purification equipment
Recent Developments
(January 2024) Completed acquisition of Uncle Bud's Hemp, expanding into CBD-based wellness and nutraceutical products
(2024) Launched new consumer products unit generating significant commercial demand from retail partners
(2024) Published multiple peer-reviewed articles validating UltraShear technology applications in food safety and pharmaceutical formulation
Open the full interactive Pressure BioSciences Inc report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.